Prestige Consumer Healthcare Inc (PBH)
70.01
-0.13
(-0.19%)
USD |
NYSE |
Apr 26, 11:12
Prestige Consumer Healthcare Cash from Investing (Quarterly): -4.496M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.496M |
| September 30, 2023 | -2.934M |
| June 30, 2023 | 2.323M |
| March 31, 2023 | -6.358M |
| December 31, 2022 | -1.803M |
| September 30, 2022 | -2.376M |
| June 30, 2022 | -1.047M |
| March 31, 2022 | -3.293M |
| December 31, 2021 | -20.23M |
| September 30, 2021 | -231.67M |
| June 30, 2021 | -1.323M |
| March 31, 2021 | -4.896M |
| December 31, 2020 | -5.728M |
| September 30, 2020 | -9.066M |
| June 30, 2020 | -2.553M |
| March 31, 2020 | -8.265M |
| December 31, 2019 | -2.483M |
| September 30, 2019 | -3.866M |
| June 30, 2019 | -1.956M |
| March 31, 2019 | -3.341M |
| December 31, 2018 | -2.065M |
| September 30, 2018 | 63.31M |
| June 30, 2018 | -2.469M |
| March 31, 2018 | -2.876M |
| December 31, 2017 | -4.871M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.231M |
| June 30, 2017 | -1.584M |
| March 31, 2017 | -804.88M |
| December 31, 2016 | 59.26M |
| September 30, 2016 | 51.92M |
| June 30, 2016 | -0.895M |
| March 31, 2016 | -228.01M |
| December 31, 2015 | 6.38M |
| September 30, 2015 | -0.903M |
| June 30, 2015 | -0.436M |
| March 31, 2015 | -2.401M |
| December 31, 2014 | 7.68M |
| September 30, 2014 | -732.05M |
| June 30, 2014 | -78.49M |
| March 31, 2014 | -0.106M |
| December 31, 2013 | -0.339M |
| September 30, 2013 | -56.17M |
| June 30, 2013 | -1.362M |
| March 31, 2013 | -1.346M |
| December 31, 2012 | 18.04M |
| September 30, 2012 | -4.068M |
| June 30, 2012 | -1.409M |
| March 31, 2012 | -663.05M |
| December 31, 2011 | -0.051M |
| September 30, 2011 | 0.969M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-231.67M
Minimum
Sep 2021
2.323M
Maximum
Jun 2023
-16.42M
Average
-3.293M
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | -0.056M |
| Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 71.47M |
| Cash from Financing (Quarterly) | -64.84M |
| Free Cash Flow | 232.04M |
| Free Cash Flow Per Share (Quarterly) | 1.386 |
| Free Cash Flow to Equity (Quarterly) | 133.11M |
| Free Cash Flow to Firm (Quarterly) | 82.11M |
| Free Cash Flow Yield | 6.62% |